NCT03127358View on ClinicalTrials.gov

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Hepatitis CMedication Adherence
Interventions
DEVICE

AiCure

Smartphone App

DEVICE

AiCure with gamification

Smartphone App with gaming.

Trial Locations (1)

10461

Albert Einstein College of Medicine Division of Substance Abuse clinics, The Bronx

Sponsors

Collaborators (1)

AiCure
All Listed Sponsors
collaborator

AiCure

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Albert Einstein College of Medicine

OTHER

NCT03127358 - Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs | Biotech Hunter | Biotech Hunter